結構性心臟病器材市場規模、佔有率和成長分析（按產品、手術和地區分類）－2026-2033年產業預測

全球結構性心臟器材市場規模預計在 2024 年達到 155 億美元，從 2025 年的 170.7 億美元成長到 2033 年的 368.5 億美元，在預測期（2026-2033 年）內複合年成長率為 10.1%。

全球結構性心臟器械市場正經歷顯著成長，這主要得益於系統性心臟病的高發生率。在美國，約有6000萬成年人患有此類疾病（佔成年人口的20-25%）。這凸顯了這些器械在心臟病治療中的重要作用。治療方法包括多種經皮治療方法，旨在控制後天性和先天性心臟病。經導管主動脈瓣置換術術（TAVR）等手術的醫療成本預計將會降低，從而提高其可及性並促進其普及，尤其是在老齡化人口尋求透過聯邦醫療保險（Medicare）和醫療補助（Medicaid）獲得更多醫療保障的情況下。產業領導者加大研發投入將推動創新，進一步增強結構性心臟器材市場的產品競爭力。

全球結構性心臟病器材市場成長要素

全球結構性心臟器材市場正經歷顯著成長，主要促進因素是人口老化、缺乏運動和不健康飲食習慣導致的心臟衰竭盛行率不斷上升。這些趨勢推動了對各種心臟器械的需求，尤其是在老年族群中，主動脈瓣狹窄、二尖瓣逆流和先天性心臟疾病率不斷上升。此外，隨著醫療專業人員尋求有效治療這些複雜心臟疾病的方法，對心臟機械工程領域先進技術的需求預計將持續成長，尤其關注包括靜脈介入和封堵器在內的創新經導管療法，這將進一步推動市場發展。

全球結構性心臟病器材市場限制因素

由於先進醫療技術和微創手術成本高昂，結構性心臟病器材市場面臨嚴峻挑戰。在醫療資源有限的地區，器械本身及其相關治療的費用可能會限制許多患者，尤其是中低收入患者獲得治療的機會。這種經濟障礙可能會阻礙市場成長和普及，因為患者難以負擔必要的治療費用。此外，某些地區的報銷問題進一步加劇了這種情況，使患者無法尋求治療，阻礙了市場的整體發展。

全球結構性心臟病器材市場趨勢

全球結構性心臟病器材市場正經歷重大變革，其主要驅動力是經導管主動脈瓣置換術術（TAVR）系統的日益普及。 TAVR作為一種治療重度主動脈瓣狹窄的手段，尤其適用於不適合傳統外科手術的患者，正逐漸受到青睞。 TAVR手術的微創特性帶來了良好的臨床療效，從而推動了對這些先進器械的需求成長。為此，製造商正大力投資研發新一代TAVR系統，旨在擴大患者覆蓋範圍並改善治療效果。這一趨勢不僅標誌著結構性心臟疾病治療方式的革新，也預示著整個市場將迎來強勁的成長動能。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭格局概述

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 技術評估

全球結構性心臟病器材市場規模（依產品及複合年成長率分類）（2026-2033 年）

• 心臟瓣膜裝置
  • 經導管心臟瓣膜
  • 外科心臟瓣膜
  • 生物瓣膜
  • 機械心臟瓣膜
• 閉合裝置及輸送系統
• 環狀成形術環
• 配件
• 其他設備

全球結構性心臟病器材市場規模（依手術類型和複合年成長率分類）（2026-2033 年）

• 置換術
  • 經導管主動脈瓣置換術
  • SAVR手術
• 恢復
  • 結紮程序
  • 瓣環成形術
  • 瓣環成形

全球結構性心臟病器材市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Boston Scientific Corporation
• Medtronic
• Edwards Lifesciences Corporation
• Abbott Laboratories
• St. Jude Medical
• Biomerics
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
• CardioKinetix
• Lepu Medical Technology
• CryoLife
• Micro Interventional Devices
• Braile Biomedica
• TTK Healthcare

結論與建議

Global Structural Heart Devices Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 17.07 Billion in 2025 to USD 36.85 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global structural heart devices market is experiencing significant growth driven by the high prevalence of systemic heart diseases, affecting approximately 60 million individuals in the U.S., representing 20-25% of the adult population. This highlights the crucial role of these devices in addressing cardiac defects. Treatments encompass a variety of percutaneous therapies aimed at managing both acquired and congenital heart conditions. As healthcare costs for procedures like Transcatheter Aortic Valve Replacement (TAVR) are projected to improve, affordability will rise, encouraging adoption, particularly as the aging population seeks care covered by Medicare and Medicaid services. Increased investment in research and development by industry leaders fuels innovation, further enhancing product offerings and competition within the structural heart devices market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Structural Heart Devices Market Segments Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing significant growth driven by the rising prevalence of heart failure, largely attributed to an aging population, inactive lifestyles, and unhealthy dietary habits. These trends are resulting in a heightened need for various cardiac devices, especially as conditions like aortic stenosis, mitral regurgitation, and congenital heart defects are increasingly diagnosed among older individuals. Moreover, the demand for sophisticated advancements in cardiac mechanical engineering is expected to continue, with a particular focus on innovative transcatheter interventions, including vein treatments and occluders, further propelling the market forward as healthcare professionals seek effective solutions for these complex heart conditions.

Restraints in the Global Structural Heart Devices Market

The Global Structural Heart Devices market faces significant challenges due to the high costs associated with these advanced medical technologies and their minimally invasive procedures. In regions where healthcare support is limited, the expense of both the devices and the associated treatments can restrict access for many patients, particularly those in low- to middle-income brackets. This financial barrier can hinder market growth and adoption rates, as individuals may struggle to afford the necessary care. Moreover, reimbursement issues in certain areas further exacerbate the situation, dissuading patients from seeking treatment and impeding overall market progress.

Market Trends of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing a significant shift driven by the growing adoption of Transcatheter Aortic Valve Replacement (TAVR) systems, which are increasingly favored for treating severe aortic stenosis, particularly among patients deemed unsuitable for conventional surgical interventions. The minimally invasive nature of TAVR procedures has garnered positive clinical outcomes, prompting heightened demand for these advanced devices. In response, manufacturers are making substantial investments in the development of next-generation TAVR systems, aiming to broaden patient eligibility and enhance treatment efficacy. This trend not only signifies an evolving approach to managing structural heart conditions but also indicates a robust growth trajectory for the market overall.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Structural Heart Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Market Overview
• Heart Valve Devices
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves
• Occluders & Delivery Systems
• Annuloplasty Rings
• Accessories
• Other Devices

Global Structural Heart Devices Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Replacement Procedures
  • TAVR Procedures
  • SAVR Procedures
• Repair Procedures
  • Closure Procedures
  • Annuloplasty
  • Valvuloplasty

Global Structural Heart Devices Market Size & CAGR (2026-2033)

• North America (Product, Procedure)
  • US
  • Canada
• Europe (Product, Procedure)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Comed BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioKinetix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations